Simulations Plus, Inc.
Simulations Plus, Inc. (SLP) develops modelling and simulation software used across pharmaceutical and biotechnology R&D to predict absorption, distribution, metabolism, excretion and toxicity (ADMET) and support pharmacokinetic/pharmacodynamic (PK/PD) studies. Its products and consulting services aim to shorten drug development timelines and reduce experimental costs, with revenue from software licences, cloud offerings and professional services. As a smaller capitalisation company, growth often depends on adoption by drug developers, recurring licence renewals and occasional acquisitions. Investors should watch product validation, regulatory acceptance of in-silico methods and partnerships with larger CROs or pharma firms. Key risks include competitive pressure from larger vendors, reliance on R&D budgets and periodic revenue volatility. This is general educational information and not personal financial advice; suitability depends on your circumstances and risk tolerance, and past performance is no guarantee of future returns.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Simulations Plus stock, which has significant growth potential based on its target price.
Financial Health
Simulations Plus is showing strong revenue, cash flow, and profit margins, indicating solid financial performance.
Dividend
Simulations Plus, Inc. has a low dividend yield of 1%. If you invested $1000 you would be paid $10 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring SLP
Digital Twin Trailblazers
Shaping the future through advanced digital twin technology first.
Published: June 20, 2025
Explore BasketDigital Twin Creators
Discover companies building virtual replicas of real-world objects and systems that are transforming how industries operate. These carefully selected stocks represent leaders in simulation, 3D modeling, and data analytics that are unlocking major efficiency gains across the global industrial landscape.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Recurring Revenue Potential
Licence and cloud subscriptions can create predictable income streams, though revenue can still vary with contract timing and renewals.
Tech Adoption Trend
In‑silico modelling is gaining regulatory and industry interest, which may support long‑term demand, but acceptance is gradual and not guaranteed.
Partnership Opportunities
Collaborations with pharmaceutical companies and CROs can expand reach; investors should note dependency risks and the competitive landscape.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
